News >

Recognizing Predisposition Syndromes Can Impact Pediatric MDS and AML Treatment

Angelica Welch
Published: Friday, Sep 14, 2018

Marcin Wlodarski, MD
Marcin Wlodarski, MD
Early identification of inherited predisposition to forms of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in pediatric patients can assist in treatment decisions and selection for familial stem cell transplant, said Marcin Wlodarski, MD, in a presentation during the 2018 SOHO Annual Meeting.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication